Min Seok Lee, BME graduate student, has been awarded for his outstanding podium presentation at the “Young Pioneer Session” of the 2020 Annual Spring Meeting of the Korean BioChip Society
A BME graduate student (MS-PhD integrated course), has been awarded for his outstanding podium presentation on rapid sepsis diagnosis method at the “Young Pioneer Session” of the 2020 Annual Spring Meeting of the Korean BioChip Society
Min Seok Lee, a graduate student (Advisor: Professor Joo Hun Kang, Department of Biomedical Engineering) at UNIST has been honored for his outstanding podium presentation at the 2020 annual Korean Biochip Society (KBCS) Conference, which took place from July 8 to 10, 2020.
He is currently pursuing his MS-PhD integrated course under the supervision of Professor Joo Hun Kang and conducting his research on developing rapid diagnostic methods for infectious diseases. At the “Young Pioneer Session” of the conference, he presented his research work entitled “Microfluidic Inflammatory Vascular-mimetics to Enable Leukocyte Rolling and Adhesion for Rapid Sepsis Diagnosis”, which was conducted with colleagues; Seyong Kwon (Research Assistant Professor) and Amanzhol Kurmashev (Master’s degree candidate) in the Translational Multiscale Biofluidics (TMB) Lab of the Department of Biomedical Engineering at UNIST.
Biochip is a core technology in studying for Bio-MEMS, biosensor, nano-convergence, and healthcare that are newly emerging bioscience area in the 21st century. Every year, a variety of biochip researchers from academic and industrial fields gather together in the KBCS to present their research results and share multidisciplinary ideas for the most recent biochip topics.
This year the KBCS conference was held on/offline due to the coronavirus crisis with a theme entitled “Biochip in Pandemic Era (COVID-19 Special Session)”, and a total of 231 abstracts were presented in the conference.
Professor Kang’s current research interests include developing biomedical engineering tools for treating and diagnosing infectious diseases and cancers, and various miniaturized biomimetic physiological devices, such as organ-on-a-chips.